| 1 |
Pangas SA, Rademaker AW, Fishman DA, Woodruff TK. Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J Clin Endocrinol Metab 2002; 87: 2644-57
DOI
ScienceOn
|
| 2 |
Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. Faseb J 1999; 13: 2105-24
DOI
PUBMED
|
| 3 |
Mizunuma H, Liu X, Andoh K, Abe Y, Kobayashi J, Yamada K, et al. Activin from secondary follicles causes small preantral follicles to remain dormant at the resting stage. Endocrinology 1999; 140: 37-42
DOI
ScienceOn
|
| 4 |
Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab 1991; 72: 1206-11
DOI
PUBMED
|
| 5 |
Tomic D, Brodie SG, Deng C, Hickey RJ, Babus JK, Malkas LH, et al. Smad 3 may regulate follicular growth in the mouse ovary. Biol Reprod 2002; 66: 917-23
DOI
ScienceOn
|
| 6 |
Lee WS, Otsuka F, Moore RK, Shirnasaki S. Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 2001; 65: 994-9
DOI
ScienceOn
|
| 7 |
Yi SE, LaPolt PS, Yoon BS, Chen JY, Lu JK, Lyons KM. The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci U S A 2001; 98: 7994-9
DOI
ScienceOn
|
| 8 |
Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002; 23: 787-823
DOI
ScienceOn
|
| 9 |
Nilsson EE, Skinner MK. Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod 2003; 69: 1265-72
DOI
ScienceOn
|
| 10 |
Solloway MJ, Dudley AT, Bikoff EK. Lyons KM, Hogan BL, Robertson EJ. Mice lacking Bmp6 function. Dev Genet 1998; 22: 321-39
DOI
ScienceOn
|
| 11 |
Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, et al. Anti-rnullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995; 136: 4951-62
DOI
PUBMED
ScienceOn
|
| 12 |
Behringer RR, Finegold MJ, Cate RL. Mullerian-inhibiting substance function during mammalian sexual development. Cell 1994; 79: 415-25
DOI
ScienceOn
|
| 13 |
Duffy DM. Growth differentiation factor-9 is expressed by the primate follicle throughout the periovulatory interval. Biol Reprod 2003; 69: 725-32
DOI
PUBMED
ScienceOn
|
| 14 |
Hayashi M, McGee EA, Min G, Klein C, Rose UM, van Duin M, et al. Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 1999; 140: 1236-44
DOI
ScienceOn
|
| 15 |
Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999; 13: 1035-48
DOI
ScienceOn
|
| 16 |
Parrott JA, Skinner MK. Kit ligand actions on ovarian stromal cells: effects on theca cell recruitment and steroid production. Mol Reprod Dev 2000; 55: 55-64
DOI
ScienceOn
|
| 17 |
Kaivo-Oja N, Bondestam J, Kamarainen M, Koskimies J, Vitt U, Cranfield M, et al. Growth differentiation factor-9 induces Smadl activation and inhibin B production in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 2003; 88: 755 -62
DOI
ScienceOn
|
| 18 |
Vitt UA, Hayashi M, Klein C, Hsueh AJ. Growth differentiation factor-9 stimulates proliferation but suppresses the folliclestimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 2000; 62: 370-7
DOI
ScienceOn
|
| 19 |
Mazerbourg S, Hsueh AJ. Growth differentiation factor-9 signaling in the ovary. Mol Cell Endocrinol 2003; 202: 31-6
DOI
PUBMED
|
| 20 |
Otsuka F, Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA 2002; 99: 8060-5
DOI
ScienceOn
|
| 21 |
Vitt UA, Mazerbourg S, Klein C, Hsueh AJ. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol Reprod 2002; 67: 473-80
DOI
ScienceOn
|
| 22 |
Liu J, Kuulasmaa T, Kosma VM, Butzow R, UAnttinen T, Hyden-Granskog C, et al. Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 2003; 88: 5002-
DOI
ScienceOn
|
| 23 |
Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol 2001; 15: 946-59
DOI
ScienceOn
|
| 24 |
Rodgers RJ, Irving-Rodgers HF, Russell DL. Extracellular matrix of the developing ovarian follicle. Reproduction 2003; 126: 415-24
DOI
PUBMED
ScienceOn
|
| 25 |
Harlow CR, Rae M, Davidson L, Trackman PC, Hillier SG. Lysyl oxidase gene expression and enzyme activity in the rat ovary: regulation by follicle-stimulating hormone, androgen, and transforming growth factor-beta superfamily members in vitro. Endocrinology 2003; 144: 154-62
DOI
PUBMED
ScienceOn
|
| 26 |
Harlow CR, Davidson L, Bums KH, Yan C, Matzuk MM, Hillier SG. FSH and TGF-beta superfamily members regulate granulosa cell connective tissue growth factor gene expression in vitro and in vivo. Endocrinology 2002; 143: 3316-25
DOI
PUBMED
ScienceOn
|
| 27 |
Attia GR, Dooley CA, Rainey WE, Carr BR. Transforming growth factor beta inhibits steroidogenic acute regulatory (StAR) protein expression in human ovarian thecal cells. Mol Cell Endocrinol 2000; 170: 123-9
DOI
PUBMED
ScienceOn
|
| 28 |
Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996; 383: 531-5
DOI
ScienceOn
|
| 29 |
Hsueh AJ, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW, et al. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci U S A 1987; 84: 5082-6
DOI
|
| 30 |
Roberts VJ, Barth S, el-Roeiy A, Yen SS. Expression of inhibin/ activin subunits and follistat in messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 1993; 77: 1402-10
DOI
ScienceOn
|
| 31 |
Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000; 404: 411-4
DOI
ScienceOn
|
| 32 |
Moore RK, Otsuka F, Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem 2003; 278: 304-10
DOI
ScienceOn
|
| 33 |
Knight PG, Glister C. Local roles of TGF-beta superfamily members in the control of ovarian follicle development. Anim Reprod Sci 2003; 78: 165-83
DOI
ScienceOn
|
| 34 |
Drummond AE, Le MT, Ethier JF, Dyson M, Findlay JK. Expression and localization of activin receptors, Smads, and beta glycan to the postnatal rat ovary. Endocrinology 2002; 143: 1423-33
DOI
ScienceOn
|
| 35 |
Jaatinen R, Bondestam J, Raivio T, Hilden K. Dunkel L, Groome N, et al. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosaluteal cells. J Clin Endocrinol Metab 2002; 87: 1254-61
DOI
ScienceOn
|
| 36 |
Wiater E, Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. J Biol Chem 2003; 278: 7934-41
DOI
ScienceOn
|
| 37 |
Drummond AE, Dyson M, Le MT, Ethier JF, Findlay JK. Ovarian follicle populations of the rat express TGF-beta signalling pathways. Mol Cell Endocrinol 2003; 202: 53-7
DOI
PUBMED
ScienceOn
|
| 38 |
Lin SY, Morrison JR, Phillips DJ, de Kretser DM. Regulation of ovarian function by the TGF-beta superfamily and follistatin. Reproduction 2003; 126: 133-48
DOI
PUBMED
ScienceOn
|
| 39 |
Souza CJ, Campbell BK, McNeilly AS, Baird DT. Effect of bone morphogenetic protein 2 (BMP2) on oestradiol and inhibin A production by sheep granulosa cells, and localization of BMP receptors in the ovary by immunohistochemistry. Reproduction 2002; 123: 363-9
DOI
PUBMED
ScienceOn
|
| 40 |
Solovyeva EV, Hayashi M, Margi K, Barkats C, Klein C, Amsterdam A, et al. Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis. Biol Reprod 2000; 63: 1214-8
DOI
ScienceOn
|
| 41 |
Inoue K, Nakamura K, Abe K, Hirakawa T, Tsuchiya M, Matsuda H, et al. Effect of transforming growth factor beta on the expression of luteinizing hormone receptor in cultured rat granulosa cells. Biol Reprod 2002; 67: 610-5
DOI
ScienceOn
|
| 42 |
Alak BM, Coskun S, Friedman CI, Kennard EA, Kim MH, Seifer DB. Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitro. Fertil Steril 1998; 70; 1126-30
DOI
ScienceOn
|
| 43 |
Vitale AM, Gonzalez OM, Parborell F, Irusta G, Campo S, Tesone M. Inhibin a increases apoptosis in early ovarian antral follicles of diethylstilbestrol-treated rats. Biol Reprod 2002; 67: 989-95
|
| 44 |
Otsuka F, Moore RK, Iemura S, Ueno N, Shimasaki S. Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 2001; 289: 961-6
DOI
ScienceOn
|
| 45 |
Duleba AJ, Pehlivan T, Carbone R, Spaczynski RZ. Activin stimulates proliferation of rat ovarian thecal-interstitial cells. Biol Reprod 2001; 65: 704-9
DOI
ScienceOn
|
| 46 |
Xu J, Oakley J, McGee EA. Stage-specific expression of smad2 and smad3 during folliculogenesis. Biol Reprod 2002; 66: 1571-8
DOI
ScienceOn
|
| 47 |
Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001; 142: 4891-9
DOI
ScienceOn
|
| 48 |
McIntush EW, Smith ME Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Rev Reprod 1998; 3: 23-30
DOI
ScienceOn
|
| 49 |
Shirnasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, et al. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci V S A 1999; 96: 7282-7
DOI
|
| 50 |
Roh JS, Bondestam J, Mazerbourg S, Kaivo-Oja N, Groome N, Ritvos O, et al. Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cells. Endocrinology 2003; 144: 172-8
DOI
ScienceOn
|
| 51 |
Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ. Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol 1991; 75: R1-6
DOI
ScienceOn
|
| 52 |
Erickson GF, Shirnasaki S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol 2003; 1: 9-29
DOI
ScienceOn
|
| 53 |
Nilsson EE, Skinner MK. Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development. Biol Reprod 2002; 67: 1018-24
DOI
ScienceOn
|
| 54 |
Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002; 124: 601-9
DOI
PUBMED
ScienceOn
|
| 55 |
Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM, Ethier JF. Recruitment and development of the follicle; the roles of the transforming growth factor-beta superfamily. Mol Cell Endocrinol 2002; 191: 35-43
DOI
PUBMED
ScienceOn
|
| 56 |
Roy SK, Kole AR. Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles. Mol Hum Reprod 1998; 4: 207-14
DOI
ScienceOn
|
| 57 |
Bondestam J, Kaivo-oja N, Kallio J, Groome N, HydenGranskog C, Fujii M, et al. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells. Mol Cell Endocrinol 2002; 195: 79-88
DOI
PUBMED
ScienceOn
|
| 58 |
Hreinsson JG, Scott JE, Rasmussen C, Swahn ML, Hsueh AJ, Hovatta O. Growth differentiation factor-9 promotes the growth, development, and surviUAl of human ovarian follicles in organ culture. J Clin Endocrinol Metab 2002; 87: 316-21
DOI
ScienceOn
|
| 59 |
Meunier H, Cajander SB, Roberts VJ, Rivier C, Sawchenko PE, Hsueh AJ, et al. Rapid changes in the expression of inhibin alpha-, beta A, and beta B-subunits in ovarian cell types during the rat estrous cycle. Mol Endocrinol 1998; 2: 1352-63
DOI
ScienceOn
|
| 60 |
Saragueta PE, Lanuza GM, Baranao JL. Autocrine role of transforming growth factor betal on rat granulosa cell proliferation. Biol Reprod 2002; 66: 1862-8
DOI
ScienceOn
|
| 61 |
Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002; 143: 1076-84
DOI
ScienceOn
|
| 62 |
Vitt VA, McGee EA, Hayashi M, Hsueh AJ. In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 2000; 141: 3814-20
DOI
ScienceOn
|
| 63 |
Chegini N, Flanders KC. Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinology 1992; 130: 1707-15
DOI
ScienceOn
|
| 64 |
Otsuka F, Yao Z, Lee T, Yamamoto S, EricksonGF, Shimasaki S. Bone morphogenetic protein-15 . Identification of target cells and biological functions. J Biol Chem 2000; 275: 39523 -8
DOI
ScienceOn
|
| 65 |
Otsuka F, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 2001; 276: 11387-92
DOI
ScienceOn
|
| 66 |
Ami KY, Ohshima K, Watanabe G, Arai K, Uehara K, Taya K. Dynamics of messenger RNAs encoding inhibin/activin subunits and follistatin in the ovary during the rat estrous cycle. Biol Reprod 2002; 66: 1119-26
DOI
ScienceOn
|
| 67 |
Dooley CA, Attia GR, Rainey WE, Moore DR, Carr BR. Bone morphogenetic protein inhibits ovarian androgen production. J Clin Endocrinol Metab 2000; 85: 3331-7
DOI
ScienceOn
|
| 68 |
Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999; 140: 5789-96
DOI
ScienceOn
|
| 69 |
Otsuka F, Moore RK, Shimasaki S. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem 2001; 276: 32889-95
DOI
ScienceOn
|
| 70 |
Albertini DF, Combelles CM, Benecchi E, Carabatsos MJ. Cellular basis for paracrine regulation of ovarian follicle development. Reproduction 2001; 121: 647-53
DOI
PUBMED
|
| 71 |
Drummond AE, Dyson M, Thean E, Groome NP, Robertson DM, Findlay JK. Temporal and hormonal regulation of inhibin protein and subunit mRNA expression by post-natal and immature rat ovaries. J Endocrinol 2000; 166: 339-54
DOI
ScienceOn
|
| 72 |
Vitt UA, Hsueh AJ. Stage-dependent role of growth differentiation factor-9 in ovarian follicle development. Mol Cell Endocrinol 2001; 183: 171-7
DOI
ScienceOn
|
| 73 |
Prendergast KA, Burger LL, Aylor KW, Haisenleder DJ, Dalkin AC, Marshall JC. Pituitary Follistatin Gene Expression in Female Rats: Evidence That Inhibin Regulates Transcription. Biol Reprod 2004 Feb; 70(2): 364-70
DOI
ScienceOn
|
| 74 |
Liu X, Andoh K, Abe Y, Kobayashi J, Yamada K, Mizunuma H, Ibuki Y. A comparative study on transforming growth factor-beta and activin A for preantral follicles from adult, immature, and diethylstilbestrol-primed immature mice. Endocrinology 1999; 140: 2480-5
DOI
ScienceOn
|
| 75 |
McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000; 21: 200-14
DOI
ScienceOn
|
| 76 |
Findlay JK, Drummond AE, Dyson M, Baillie AJ, Robertson DM, Ethier JF. Production and actions of inhibin and activin during folliculogenesis in the rat. Mol Cell Endocrinol 2001; 180: 139-44
DOI
ScienceOn
|
| 77 |
Yamamoto N, Christenson LK, McAllister JM, Strauss JF, 3rd. Growth differentiation factor-9 inhibits 3'5'-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab 2002; 87: 2849-56
DOI
ScienceOn
|
| 78 |
Sidis Y, Fujiwara T, Leykin L, Isaacson K, Toth T, Schneyer AL. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes. Biol Reprod 1998; 59: 807-12
DOI
ScienceOn
|
| 79 |
Skinner MK, Keski-Oja J, Osteen KG, Moses HL. Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. Endocrinology 1987; 121: 786-92
DOI
ScienceOn
|
| 80 |
Ethier JF, Findlay JK. Roles of activin and its signal transduction mechanisms in reproductive tissues. Reproduction 2001; 121: 667-75
DOI
PUBMED
|
| 81 |
Jirnenez-Krassel F, Winn ME, Bums D, Ireland JL, Ireland JJ. Evidence for a negative intrafollicular role for inhibin in regulation of estradiol production by granulosa cells. Endocrinology 2003; 144: 1876-86
DOI
ScienceOn
|
| 82 |
Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, et al. Mutations in an oocyte-derived growth factor gene (BMPI5) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000; 25: 279-83
DOI
ScienceOn
|
| 83 |
Ethier JF, Famworth PG, Findlay JK, Ooi GT. Transforming Growth Factor-beta Modulates Inhibin A Bioactivity in the LbetaT2 Gonadotrope Cell Line by Competing for Binding to Betaglycan. Mol Endocrinol 2002; 16: 2754-63
DOI
ScienceOn
|
webmaster
